https://www.selleckchem.com/pr....oducts/azd0156-azd-0
sed in the future as potential therapeutical targets.The accessibility of pharmacogenomic (PGx) testing has grown substantially over the last decade and with it has arisen a demand for patients to be counseled on the use of these tests. While guidelines exist for the use of PGx results; objective determinants for who should receive PGx testing remain incomplete. PGx clinical services have been created to meet these screening and education needs and significant variability exists between these programs. This article describes th
Like
Comment
Share
